Bauersachs J, Solomon SD, Anker SD, Antorrena-Miranda I, et al. Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF-REVERT trial. Eur J Heart Fail 2024;26:674-682.
PMID: 38269451